Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?

European Respiratory Journal

Volumn 40, Issue 1, 2012, Pages 161-168

  Theron, Grant ^a   Pooran, Anil ^a   Peter, Jonny ^a   Van Zyl Smit, Richard ^a   Mishra, Hridesh Kumar ^b   Meldau, Richard ^a   Calligaro, Greg ^a   Allwood, Brian ^a   Sharma, Surendra Kumar ^b   Dawson, Rod ^a   Dheda, Keertan ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Adjunct diagnostics; Chest radiography; Tuberculosis; Xpert MTB RIF

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; COST CONTROL; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; HEALTH CARE COST; HUMAN; INFORMATION PROCESSING; INTERFERON GAMMA RELEASE ASSAY; MAJOR CLINICAL STUDY; MICROSCOPY; MYCOBACTERIUM TUBERCULOSIS; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIOLOGY; SENSITIVITY AND SPECIFICITY; SMEAR MICROSCOPY; SOUTH AFRICA; THORAX RADIOGRAPHY; TUBERCULOSIS;

COSTS AND COST ANALYSIS; HEALTH RESOURCES; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA RELEASE TESTS; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; RIFAMPIN; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; SPUTUM; TUBERCULIN TEST; TUBERCULOSIS;

EID: 84863461477     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00145511     Document Type: Article

References (18)

1. World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resitance: Xpert MTB/RIF System. WHO/HTM/TB/2011.4. Geneva, World Health Organization, 2011.
2. World Health Organization. Rapid Implementation of the Xpert MTB/RIF diagnostic test. Technical and Operational "How to"Practicle Considerations. WHO/HTM/TB/2011.2. Geneva, World Health Organization, 2011.
3. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010; 363: 1005-1015.
4. Boehme CC, Nicol MP, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/ RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011; 377: 1495-1505.
5. Theron G, Peter J, van Zyl-Smit R, et al. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med 2011; 184:132-140.
6. Theron G, Peter J, Dheda K. Xpert MTB/RIF test for tuberculosis. Lancet 2011; 378: 481.
7. Dowdy DW, Cattamanchi A, Steingart KR, et al. Is scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosis. PLoS Medicine 2011; 8: e1001063.
8. Evans CA. GeneXpert - a game-changer for tuberculosis control? PLoS Med 2011; 8: e1001064.
9. Theron G, Pinto L, Peter J, et al. The use of an automated quantitative polymerase chain reaction (Xpert MTB/RIF) to predict the sputum smear status of tuberculosis patients. Clin Infect Dis 2012; 54: 384-388.
10. Helb D, Jones M, Story E, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol 2010; 48: 229-237.
11. Dawson R, Masuka P, Edwards D, et al. Chest radiograph reading and recording system: evaluation for tuberculosis screening in patients with advanced HIV. Int J Tuberc Lung Dis 2010; 14: 52-58.
12. Den Boon S, Bateman E, Enarson D, et al. Development and evaluation of a new chest radiograph reading and recording system for epidemiological surveys of tuberculosis and lung disease. Int J Tuberc Lung Dis 2005; 9: 1088-1096. (Pubitemid 41433798)
13. Dean AG, Sullivan KM, Soe MM. OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version 2.3.1. www. OpenEpi.com Date last updated: September 19, 2010. Date last accessed: November 30, 2010.
14. Sinanovic E, Floyd K, Dudley L, et al. Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa. Int J Tuberc Lung Dis 2003; 7: Suppl. 1, S56-S62. (Pubitemid 37162932)
15. Ling DI, Pai M, Davids V, et al. Are interferon-c release assays useful for diagnosing active tuberculosis in a high-burden setting? Eur Respir J 2011; 38: 649-656.
16. Rangaka MX, Gideon HP, Wilkinson KA, et al. Interferon release does not add discrimiatory value to smear negative HIV-tuberculosis algorithms. Eur Respir J 2012; 39: 163-171.
17. World Health Organization. Commercial Serodiagnostic Tests for Diagnosis of Tuberculosis. WHO/HTM/TB/2011.5. Geneva, World Health Organization, 2011.
18. Millen SJ, Uys PW, Hargrove J, et al. The effect of diagnostic delays on the drop-out rate and the total delay to diagnosis of tuberculosis. PloS One 2008; 3: e1933.